Ori Ben-Yehuda Selected Research

Ezetimibe (Zetia)

1/2014	Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years.
3/2010	Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ori Ben-Yehuda Research Topics

Disease

43	Myocardial Infarction 01/2024 - 06/2015
31	Thrombosis (Thrombus) 01/2024 - 03/2015
25	ST Elevation Myocardial Infarction 02/2024 - 02/2006
23	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 05/2013
18	Hemorrhage 03/2024 - 09/2009
16	Death (Near-Death Experience) 01/2024 - 09/2017
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 12/2006
14	Heart Failure 01/2023 - 11/2002
11	Acute Coronary Syndrome 01/2024 - 11/2002
9	Diabetes Mellitus 09/2023 - 12/2006
9	Ischemia 01/2023 - 11/2002
9	Infarction (Infarctions) 12/2022 - 11/2002
7	Stroke (Strokes) 01/2021 - 12/2017
6	Stable Angina 01/2024 - 10/2012
6	Pathologic Constriction (Stenosis) 01/2023 - 01/2004
6	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2023 - 10/2016
6	Aortic Valve Stenosis (Aortic Stenosis) 11/2022 - 01/2019
6	Hypertension (High Blood Pressure) 11/2022 - 04/2003
6	Coronary Stenosis (Coronary Artery Stenosis) 01/2020 - 11/2016
5	Chronic Renal Insufficiency 10/2020 - 01/2017
4	Hyperplasia 09/2023 - 01/2004
4	Coronary Disease (Coronary Heart Disease) 07/2021 - 12/2006
3	Atrial Fibrillation 01/2020 - 12/2017
3	Neoplasms (Cancer) 09/2015 - 07/2007
3	Type 2 Diabetes Mellitus (MODY) 01/2015 - 05/2013
3	Vascular Diseases (Vascular Disease) 01/2014 - 03/2010
2	Hypotension (Low Blood Pressure) 11/2022 - 11/2002
2	Atherosclerotic Plaque (Atheroma) 11/2022 - 11/2020
2	Heart Arrest (Cardiac Arrest) 11/2022 - 01/2021
2	Pulmonary Arterial Hypertension 01/2020 - 07/2012
2	Anemia 01/2020 - 09/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 06/2019 - 01/2019
2	Atherosclerosis 12/2017 - 01/2017
2	Bradycardia 07/2017 - 11/2002
2	Hyperglycemia 01/2017 - 10/2014
2	Pulmonary Hypertension 09/2009 - 01/2004
1	Cardiogenic Shock 12/2022
1	Wounds and Injuries (Trauma) 01/2022
1	COVID-19 01/2022
1	Drug Hypersensitivity (Drug Allergy) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Vascular System Injuries 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2020
1	Barotrauma 01/2020

Drug/Important Bio-Agent (IBA)

15	omega-Chloroacetophenone (Mace)IBA 01/2023 - 02/2016
8	Ranolazine FDA Link 01/2019 - 10/2012
7	LipidsIBA 11/2020 - 12/2006
6	ridaforolimusIBA 01/2024 - 10/2017
5	Everolimus FDA Link 01/2022 - 09/2016
4	Clopidogrel (Plavix)FDA Link 01/2023 - 01/2017
4	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2017
4	oxidized low density lipoproteinIBA 01/2014 - 12/2006
3	MetalsIBA 01/2024 - 01/2017
3	bivalirudin (Angiomax)FDA Link 01/2021 - 01/2017
3	Glycoproteins (Glycoprotein)IBA 01/2017 - 01/2004
3	Atorvastatin (Lipitor)FDA Link 01/2014 - 03/2010
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2024 - 01/2022
2	Insulin (Novolin)FDA Link 01/2023 - 01/2017
2	CobaltIBA 01/2022 - 10/2017
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2020
2	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2020
2	zotarolimusIBA 01/2020 - 10/2017
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 01/2018
2	CalciumIBA 01/2020 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 05/2017
2	C-Reactive ProteinIBA 01/2019 - 05/2007
2	AnticoagulantsIBA 01/2018 - 12/2017
2	Nitroglycerin (Dynamite)FDA LinkGeneric 10/2014 - 05/2013
2	Ezetimibe (Zetia)FDA Link 01/2014 - 03/2010
2	CholesterolIBA 03/2010 - 12/2006
2	HDL CholesterolIBA 03/2010 - 12/2006
2	LDL Lipoproteins (beta Lipoproteins)IBA 03/2010 - 07/2007
1	TicagrelorIBA 03/2024
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2024
1	umirolimusIBA 01/2024
1	apixabanIBA 01/2022
1	ChromiumIBA 01/2022
1	Fluorocarbon PolymersIBA 01/2022
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2022
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2022
1	P-30 composite resin (P 30)IBA 08/2021
1	Technetium-99IBA 01/2021
1	AntithrombinsIBA 01/2021
1	TroponinIBA 01/2020
1	IsoenzymesIBA 01/2020

Therapy/Procedure

55	Percutaneous Coronary Intervention 02/2024 - 01/2008
51	Stents 01/2024 - 01/2004
24	Therapeutics 01/2023 - 11/2002
16	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2024 - 09/2016
7	Drug-Eluting Stents 01/2024 - 03/2017
7	Transcatheter Aortic Valve Replacement 11/2022 - 12/2016
3	Patient Readmission 11/2022 - 01/2019
3	Catheters 11/2020 - 11/2019
2	Contraindications 12/2017 - 11/2002
2	Endarterectomy (Thromboendarterectomy) 09/2009 - 01/2004
1	Heart-Assist Devices 12/2022
1	Defibrillators (Defibrillator) 12/2022
1	Vascular Closure Devices 08/2021